本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Vera Therapeutics, Inc.

21.11
-0.1800-0.85%
盘后21.110.00000.00%19:56 EDT
成交量:92.23万
成交额:1,963.61万
市值:13.46亿
市盈率:-7.68
高:21.90
开:21.13
低:20.84
收:21.29
数据加载中...
2024/10/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/02

重要事件披露

Form 8-K - Current report
2024/09/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/07/03

重要事件披露

Form 8-K - Current report
2024/06/12

重要事件披露

Form 8-K - Current report
2024/05/17

重要事件披露

Form 8-K - Current report
2024/05/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/26

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]